A comparison of anticoagulants for the analysis of glucose concentration and for haematological measurements in bovine blood.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to R H Whitlock.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Equine antiserum to core lipopolysaccharide (LPS) was evaluated in a double-blind prospective study for therapeutic benefit in suspected septicemia in neonatal foals. Forty foals younger than 7 days of age were included in the study by satisfaction of clinical and laboratory criteria, suggestive of gram-negative septicemia. Twenty-two foals were treated with core LPS antiserum (plasma produced from horses which were hyperimmunized with rough gram-negative mutant bacterin) and 18 foals received "nonimmune" plasma (from horses prior to immunization against core LPS). All foals received antimicrobials, fluids, and other supportive care measures, depending on clinical signs and according to accepted current practice. The clinical and laboratory data of each foal were monitored and recorded daily for 14 days after plasma treatment or until death. The overall survival rate of these 40 foals with septicemia was 52.5%. The most prevalent diagnoses in addition to septicemia were enteritis and pneumonia. Of 30 positive bacterial cultures, 93% were due to gram-negative organisms. There was no statistically significant increase in survival rate in the 22 foals given core LPS antiserum (P greater than 0.05).
Hepatic failure developed following mastitis or metritis in five adult cows. In all five cases, cows initially showed clinical signs compatible with endotoxemia, which resolved with appropriate therapy for the mastitis or metritis. Subsequently, signs of liver failure developed including profound anorexia, weight loss, cessation of milk production, and in one case, photosensitization. Four cows had laboratory evidence of liver disease and failure (abnormally prolonged sulfobromophthalein [BSP] clearance half-life and abnormally high serum liver enzyme activity). Hepatocellular necrosis or vacuolization was seen on histopathologic examination of liver specimens from all five cows. The hepatocellular necrosis, in some cases, was thought to be due to the direct or indirect effects of endotoxin on the liver. Three of the cows responded to symptomatic therapy. One cow failed to respond and one was not treated.
A 10-month-old Arabian foal was evaluated for a suspected immunoglobulin (Ig) M deficiency. Decreased to nondetectable concentrations of IgM, IgA, and IgG (T), and a normal concentration of IgG, were present. Results of in vitro testing of the blood lymphocyte blastogenesis showed a weak response to the B-cell mitogen, lipopolysaccharide (LPS), but normal responses to T-cell mitogens. Results of postmortem examination showed synovitis of the left tibiotarsal and both scapulohumeral joints. Atrophy and edema of the lymph nodes and lymphocyte depletion in the thymus and spleen were seen. A subacute inflammatory infiltrate was observed in the kidney, synovium, liver, and brain. Etiologic agents were not identified. This case represents a previously unreported form of immunodeficiency disease in the horse.